{"disease":{"id":"peg-aspargase","name":"peg aspargase"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03936452","title":"Combined Treatment of Sintilimab, Peg-aspargase Plus Anlotinib in NK/T Cell Lymphoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"Sun Yat-sen University","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}